CAS 2031161-35-8

Fórmula: C20H15F4N3O2

InChI: InChI=1S/C20H15F4N3O2/c1-19(29,11-27-7-6-12-8-14(21)3-5-17(12)27)18(28)26-15-4-2-13(10-25)16(9-15)20(22,23)24/h2-9,29H,11H2,1H3,(H,26,28)/t19-/m0/s1

Clave InChI: CFSAYQVTXBMPRF-IBGZPJMESA-N

SMILES: C[C@](CN1C=CC2=C1C=CC(=C2)F)(C(=O)NC3=CC(=C(C=C3)C#N)C(F)(F)F)O

UT-155

CAS: 2031161-35-8

UT-155

Fórmula: C₂₀H₁₅F₄N₃O₂

Pureza: ≥98%

Peso molecular: 405.35

Ref: 54-BUP08922

UT-155

CAS: 2031161-35-8

UT-155 is a selective and potent antagonist of the androgen receptor (AR) (Ki: 267 nM for UT-155 binding to AR-LBD).

Fórmula: C₂₀H₁₅F₄N₃O₂

Pureza: 98.94%

Forma y color: White Solid

Peso molecular: 405.3456

Ref: TM-T13272

UT-155

CAS: 2031161-35-8

Fórmula: C₂₀H₁₅F₄N₃O₂

Pureza: 99.39%

Peso molecular: 405.3456

Ref: IN-DA01EO6H

UT-155

CAS: 2031161-35-8

(S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(5-fluoro-1H-indol-1-yl)-2-hydroxy-2-methylpropanamide

Fórmula: C₂₀H₁₅F₄N₃O₂

Pureza: 99.39%

Peso molecular: 405.35

Ref: IN-DG01112028

UT-155

CAS: 2031161-35-8

UT-155 is a monoclonal antibody that binds to the ubiquitin-proteasome receptor. It is used in research to study the mechanism of ubiquitin-proteasome function in cells. UT-155 has been shown to inhibit prostate cancer cells and leukemia cells, as well as reduce tumor size in mice with prostate cancer. This drug also inhibits the production of ferroptosis and splicing, which are pro-apoptotic processes.

Fórmula: C₂₀H₁₅F₄N₃O₂

Pureza: Min. 95%

Peso molecular: 405.3 g/mol

Ref: 3D-GGD16135